| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 76.8 | 0.5 | 0.2 | - | - | - | - | - | - | - | 77.5 |
| 1 | 197.5 | 0.5 | 0.2 | - | - | - | - | - | - | - | 198.2 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 10 |
| 1 | 4 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | - |
| 1 | - |
| Number of post synapses: | 310 |
| Number of pre synapses: | 793 |
| Number of output connections: | 1836 |
| Coverage factor: | 1.2 |
| Columnar completeness: | 0.38 |
| Area completeness: | 0.86 |
| Cell size (columns): | 110 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#l-LNv (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi1 (R) | ACh | 65 | 16.2 | 18.8% | 18.8% |
| 1 | aMe4 (R) | ACh | 49 | 12.2 | 14.2% | 33.0% |
| 2 | aMe17e (R) | Glu | 26 | 6.5 | 7.5% | 40.6% |
| 3 | Tm3 (R) | ACh | 19 | 4.8 | 5.5% | 46.1% |
| 4 | OA-AL2i3 (R) | OA | 18 | 4.5 | 5.2% | 51.3% |
| 5 | aMe2 (R) | Glu | 15 | 3.8 | 4.3% | 55.7% |
| 6 | Dm9 (R) | Glu | 15 | 3.8 | 4.3% | 60.0% |
| 7 | Mi15 (R) | ACh | 13 | 3.2 | 3.8% | 63.8% |
| 8 | MeVPMe12 (L) | ACh | 11 | 2.8 | 3.2% | 67.0% |
| 9 | R8p (R) | His | 10 | 2.5 | 2.9% | 69.9% |
| 10 | l-LNv (L) | unclear | 7 | 1.8 | 2.0% | 71.9% |
| 11 | L3 (R) | ACh | 7 | 1.8 | 2.0% | 73.9% |
| 12 | R7p (R) | His | 7 | 1.8 | 2.0% | 75.9% |
| 13 | aMe30 (R) | Glu | 6 | 1.5 | 1.7% | 77.7% |
| 14 | L1 (R) | Glu | 6 | 1.5 | 1.7% | 79.4% |
| 15 | l-LNv (R) | unclear | 5 | 1.2 | 1.4% | 80.9% |
| 16 | MeVPMe12 (R) | ACh | 5 | 1.2 | 1.4% | 82.3% |
| 17 | Mi19 (R) | 5HT | 5 | 1.2 | 1.4% | 83.8% |
| 18 | L5 (R) | ACh | 4 | 1.0 | 1.2% | 84.9% |
| 19 | Lawf1 (R) | ACh | 4 | 1.0 | 1.2% | 86.1% |
| 20 | MeVCMe1 (R) | ACh | 4 | 1.0 | 1.2% | 87.2% |
| 21 | R8y (R) | His | 4 | 1.0 | 1.2% | 88.4% |
| instance | NT | total connections | connections /#l-LNv (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Mi1 (R) | ACh | 690 | 172.5 | 35.9% | 35.9% |
| 1 | Tm3 (R) | ACh | 508 | 127.0 | 26.4% | 62.3% |
| 2 | Lawf1 (R) | ACh | 82 | 20.5 | 4.3% | 66.6% |
| 3 | Tm5c (R) | Glu | 63 | 15.8 | 3.3% | 69.9% |
| 4 | Tm6 (R) | ACh | 40 | 10.0 | 2.1% | 72.0% |
| 5 | Dm9 (R) | Glu | 39 | 9.8 | 2.0% | 74.0% |
| 6 | Cm35 (R) | GABA | 30 | 7.5 | 1.6% | 75.5% |
| 7 | C3 (R) | GABA | 27 | 6.8 | 1.4% | 77.0% |
| 8 | Dm6 (R) | Glu | 27 | 6.8 | 1.4% | 78.4% |
| 9 | aMe30 (R) | Glu | 26 | 6.5 | 1.4% | 79.7% |
| 10 | L1 (R) | Glu | 20 | 5.0 | 1.0% | 80.7% |
| 11 | Lawf2 (R) | ACh | 20 | 5.0 | 1.0% | 81.8% |
| 12 | Mi15 (R) | ACh | 20 | 5.0 | 1.0% | 82.8% |
| 13 | MeVPMe12 (R) | ACh | 19 | 4.8 | 1.0% | 83.8% |
| 14 | MeLo2 (R) | ACh | 18 | 4.5 | 0.9% | 84.8% |
| 15 | C2 (R) | GABA | 17 | 4.2 | 0.9% | 85.6% |
| 16 | Dm10 (R) | GABA | 16 | 4.0 | 0.8% | 86.5% |
| 17 | L5 (R) | ACh | 16 | 4.0 | 0.8% | 87.3% |
| 18 | Tm20 (R) | ACh | 14 | 3.5 | 0.7% | 88.0% |
| 19 | MeVCMe1 (R) | ACh | 13 | 3.2 | 0.7% | 88.7% |
| 20 | Dm20 (R) | Glu | 12 | 3.0 | 0.6% | 89.3% |
| 21 | aMe4 (R) | ACh | 11 | 2.8 | 0.6% | 89.9% |
| 22 | R8p (R) | His | 10 | 2.5 | 0.5% | 90.4% |
| 23 | R7p (R) | His | 9 | 2.2 | 0.5% | 90.9% |
| 24 | TmY5a (R) | Glu | 9 | 2.2 | 0.5% | 91.4% |
| 25 | T2 (R) | ACh | 8 | 2.0 | 0.4% | 91.8% |
| 26 | l-LNv (L) | unclear | 7 | 1.8 | 0.4% | 92.1% |
| 27 | L4 (R) | ACh | 7 | 1.8 | 0.4% | 92.5% |
| 28 | Mi4 (R) | GABA | 7 | 1.8 | 0.4% | 92.9% |
| 29 | OA-AL2i3 (R) | OA | 7 | 1.8 | 0.4% | 93.2% |
| 30 | Tm37 (R) | Glu | 7 | 1.8 | 0.4% | 93.6% |
| 31 | MeLo1 (R) | ACh | 6 | 1.5 | 0.3% | 93.9% |
| 32 | MeVCMe1 (L) | ACh | 6 | 1.5 | 0.3% | 94.2% |
| 33 | Mi14 (R) | Glu | 6 | 1.5 | 0.3% | 94.5% |
| 34 | MeVPMe12 (L) | ACh | 5 | 1.2 | 0.3% | 94.8% |
| 35 | T1 (R) | unclear | 5 | 1.2 | 0.3% | 95.1% |
| 36 | Tm12 (R) | ACh | 5 | 1.2 | 0.3% | 95.3% |
| 37 | TmY18 (R) | ACh | 5 | 1.2 | 0.3% | 95.6% |
| 38 | aMe6c (R) | Glu | 4 | 1.0 | 0.2% | 95.8% |
| 39 | Dm18 (R) | GABA | 4 | 1.0 | 0.2% | 96.0% |
| 40 | l-LNv (R) | unclear | 4 | 1.0 | 0.2% | 96.2% |
| 41 | R8_unclear (R) | His | 4 | 1.0 | 0.2% | 96.4% |